Therefore, Loricrin-IKKα transgenic mice that overexpress IKKα in the suprabasal terminally differentiated cells, which are mitotically inactive and committed to shed, develop less tumors in skin carcinogenesis experiments than WT mice [4]. This evidence concerns the gene LORICRIN and neoplasm.